On 2024-11-26 Global Info Research released【Global Alzheimer's Disease Diagnosis Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030】. This report includes an overview of the development of the Alzheimer's Disease Diagnosis industry chain, the market status of Consumer Electronics (Nickel-Zinc Ferrite Core, Mn-Zn Ferrite Core), Household Appliances (Nickel-Zinc Ferrite Core, Mn-Zn Ferrite Core), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Alzheimer's Disease Diagnosis.
Sample Report Request Alzheimer's Disease Diagnosis
https://www.globalinforesearch.com/reports/2355076/alzheimer-s-disease-diagnosis
The Alzheimer's Disease Diagnosis market encompasses the tools, technologies, and services used to detect and diagnose Alzheimer's disease, a progressive neurodegenerative disorder. This market includes diagnostic methods such as imaging techniques (like PET, MRI, and CT scans), biomarker testing (blood, cerebrospinal fluid, and genetic testing), cognitive assessment tools, and novel diagnostic solutions like digital health tools and AI-based diagnostics. The growing prevalence of Alzheimer’s, increasing awareness of early detection, and advancements in diagnostic technologies are driving market growth. Pharmaceutical companies, research institutions, and healthcare providers play key roles in expanding diagnostic options. However, challenges such as the high cost of advanced diagnostic tools and limited access to specialized testing in certain regions can restrain the market’s growth. The Alzheimer's Disease Diagnosis market is critical for facilitating early and accurate diagnosis, which can improve patient management and outcomes.
Market segment by Type：Neuroimaging Examination、Cerebrospinal Fluid Examination、Peripheral Blood Antibody Examination、Others
Market segment by Application：Clinical Diagnosis、Research
Major players covered： Roche、Quanterix、Quest Diagnostics、C₂N Diagnostics、Fujirebio、Diadem、Labcorp、Neurocode、Cognitact、EUROIMMUN Medical Diagnostics、Vazyme International、KingMed Diagnostics、Hoyotek、Carrier Biomed
Table of Contents
1 Supply Summary
1.1 Alzheimer's Disease Diagnosis Introduction
1.2 World Alzheimer's Disease Diagnosis Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Alzheimer's Disease Diagnosis Total Market by Region (by Headquarter Location)
1.3.1 World Alzheimer's Disease Diagnosis Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Based Company Alzheimer's Disease Diagnosis Revenue (2019-2030)
1.3.3 China Based Company Alzheimer's Disease Diagnosis Revenue (2019-2030)
1.3.4 Europe Based Company Alzheimer's Disease Diagnosis Revenue (2019-2030)
1.3.5 Japan Based Company Alzheimer's Disease Diagnosis Revenue (2019-2030)
1.3.6 South Korea Based Company Alzheimer's Disease Diagnosis Revenue (2019-2030)
1.3.7 ASEAN Based Company Alzheimer's Disease Diagnosis Revenue (2019-2030)
1.3.8 India Based Company Alzheimer's Disease Diagnosis Revenue (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Alzheimer's Disease Diagnosis Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 Demand Summary
2.1 World Alzheimer's Disease Diagnosis Consumption Value (2019-2030)
2.2 World Alzheimer's Disease Diagnosis Consumption Value by Region
2.2.1 World Alzheimer's Disease Diagnosis Consumption Value by Region (2019-2024)
2.2.2 World Alzheimer's Disease Diagnosis Consumption Value Forecast by Region (2025-2030)
2.3 United States Alzheimer's Disease Diagnosis Consumption Value (2019-2030)
2.4 China Alzheimer's Disease Diagnosis Consumption Value (2019-2030)
2.5 Europe Alzheimer's Disease Diagnosis Consumption Value (2019-2030)
2.6 Japan Alzheimer's Disease Diagnosis Consumption Value (2019-2030)
2.7 South Korea Alzheimer's Disease Diagnosis Consumption Value (2019-2030)
2.8 ASEAN Alzheimer's Disease Diagnosis Consumption Value (2019-2030)
2.9 India Alzheimer's Disease Diagnosis Consumption Value (2019-2030)
3 World Alzheimer's Disease Diagnosis Companies Competitive Analysis
3.1 World Alzheimer's Disease Diagnosis Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Alzheimer's Disease Diagnosis Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Alzheimer's Disease Diagnosis in 2023
3.2.3 Global Concentration Ratios (CR8) for Alzheimer's Disease Diagnosis in 2023
3.3 Alzheimer's Disease Diagnosis Company Evaluation Quadrant
3.4 Alzheimer's Disease Diagnosis Market: Overall Company Footprint Analysis
3.4.1 Alzheimer's Disease Diagnosis Market: Region Footprint
3.4.2 Alzheimer's Disease Diagnosis Market: Company Product Type Footprint
3.4.3 Alzheimer's Disease Diagnosis Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 United States VS China VS Rest of World (by Headquarter Location)
4.1 United States VS China: Alzheimer's Disease Diagnosis Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Alzheimer's Disease Diagnosis Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Alzheimer's Disease Diagnosis Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Alzheimer's Disease Diagnosis Consumption Value Comparison
4.2.1 United States VS China: Alzheimer's Disease Diagnosis Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Alzheimer's Disease Diagnosis Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Alzheimer's Disease Diagnosis Companies and Market Share, 2019-2024
4.3.1 United States Based Alzheimer's Disease Diagnosis Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Alzheimer's Disease Diagnosis Revenue, (2019-2024)
4.4 China Based Companies Alzheimer's Disease Diagnosis Revenue and Market Share, 2019-2024
4.4.1 China Based Alzheimer's Disease Diagnosis Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Alzheimer's Disease Diagnosis Revenue, (2019-2024)
4.5 Rest of World Based Alzheimer's Disease Diagnosis Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Alzheimer's Disease Diagnosis Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Alzheimer's Disease Diagnosis Revenue (2019-2024)
5 Market Analysis by Type
5.1 World Alzheimer's Disease Diagnosis Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Neuroimaging Examination
5.2.2 Cerebrospinal Fluid Examination
5.2.3 Peripheral Blood Antibody Examination
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Alzheimer's Disease Diagnosis Market Size by Type (2019-2024)
5.3.2 World Alzheimer's Disease Diagnosis Market Size by Type (2025-2030)
5.3.3 World Alzheimer's Disease Diagnosis Market Size Market Share by Type (2025-2030)
6 Market Analysis by Application
6.1 World Alzheimer's Disease Diagnosis Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Clinical Diagnosis
6.2.2 Research
6.3 Market Segment by Application
6.3.1 World Alzheimer's Disease Diagnosis Market Size by Application (2019-2024)
6.3.2 World Alzheimer's Disease Diagnosis Market Size by Application (2025-2030)
6.3.3 World Alzheimer's Disease Diagnosis Market Size Market Share by Application (2019-2030)
7 Company Profiles
7.1 Roche
7.1.1 Roche Details
7.1.2 Roche Major Business
7.1.3 Roche Alzheimer's Disease Diagnosis Product and Services
7.1.4 Roche Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Roche Recent Developments/Updates
7.1.6 Roche Competitive Strengths & Weaknesses
7.2 Quanterix
7.2.1 Quanterix Details
7.2.2 Quanterix Major Business
7.2.3 Quanterix Alzheimer's Disease Diagnosis Product and Services
7.2.4 Quanterix Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Quanterix Recent Developments/Updates
7.2.6 Quanterix Competitive Strengths & Weaknesses
7.3 Quest Diagnostics
7.3.1 Quest Diagnostics Details
7.3.2 Quest Diagnostics Major Business
7.3.3 Quest Diagnostics Alzheimer's Disease Diagnosis Product and Services
7.3.4 Quest Diagnostics Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Quest Diagnostics Recent Developments/Updates
7.3.6 Quest Diagnostics Competitive Strengths & Weaknesses
7.4 C₂N Diagnostics
7.4.1 C₂N Diagnostics Details
7.4.2 C₂N Diagnostics Major Business
7.4.3 C₂N Diagnostics Alzheimer's Disease Diagnosis Product and Services
7.4.4 C₂N Diagnostics Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 C₂N Diagnostics Recent Developments/Updates
7.4.6 C₂N Diagnostics Competitive Strengths & Weaknesses
7.5 Fujirebio
7.5.1 Fujirebio Details
7.5.2 Fujirebio Major Business
7.5.3 Fujirebio Alzheimer's Disease Diagnosis Product and Services
7.5.4 Fujirebio Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Fujirebio Recent Developments/Updates
7.5.6 Fujirebio Competitive Strengths & Weaknesses
7.6 Diadem
7.6.1 Diadem Details
7.6.2 Diadem Major Business
7.6.3 Diadem Alzheimer's Disease Diagnosis Product and Services
7.6.4 Diadem Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 Diadem Recent Developments/Updates
7.6.6 Diadem Competitive Strengths & Weaknesses
7.7 Labcorp
7.7.1 Labcorp Details
7.7.2 Labcorp Major Business
7.7.3 Labcorp Alzheimer's Disease Diagnosis Product and Services
7.7.4 Labcorp Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 Labcorp Recent Developments/Updates
7.7.6 Labcorp Competitive Strengths & Weaknesses
7.8 Neurocode
7.8.1 Neurocode Details
7.8.2 Neurocode Major Business
7.8.3 Neurocode Alzheimer's Disease Diagnosis Product and Services
7.8.4 Neurocode Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Neurocode Recent Developments/Updates
7.8.6 Neurocode Competitive Strengths & Weaknesses
7.9 Cognitact
7.9.1 Cognitact Details
7.9.2 Cognitact Major Business
7.9.3 Cognitact Alzheimer's Disease Diagnosis Product and Services
7.9.4 Cognitact Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 Cognitact Recent Developments/Updates
7.9.6 Cognitact Competitive Strengths & Weaknesses
7.10 EUROIMMUN Medical Diagnostics
7.10.1 EUROIMMUN Medical Diagnostics Details
7.10.2 EUROIMMUN Medical Diagnostics Major Business
7.10.3 EUROIMMUN Medical Diagnostics Alzheimer's Disease Diagnosis Product and Services
7.10.4 EUROIMMUN Medical Diagnostics Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 EUROIMMUN Medical Diagnostics Recent Developments/Updates
7.10.6 EUROIMMUN Medical Diagnostics Competitive Strengths & Weaknesses
7.11 Vazyme International
7.11.1 Vazyme International Details
7.11.2 Vazyme International Major Business
7.11.3 Vazyme International Alzheimer's Disease Diagnosis Product and Services
7.11.4 Vazyme International Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 Vazyme International Recent Developments/Updates
7.11.6 Vazyme International Competitive Strengths & Weaknesses
7.12 KingMed Diagnostics
7.12.1 KingMed Diagnostics Details
7.12.2 KingMed Diagnostics Major Business
7.12.3 KingMed Diagnostics Alzheimer's Disease Diagnosis Product and Services
7.12.4 KingMed Diagnostics Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.12.5 KingMed Diagnostics Recent Developments/Updates
7.12.6 KingMed Diagnostics Competitive Strengths & Weaknesses
7.13 Hoyotek
7.13.1 Hoyotek Details
7.13.2 Hoyotek Major Business
7.13.3 Hoyotek Alzheimer's Disease Diagnosis Product and Services
7.13.4 Hoyotek Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.13.5 Hoyotek Recent Developments/Updates
7.13.6 Hoyotek Competitive Strengths & Weaknesses
7.14 Carrier Biomed
7.14.1 Carrier Biomed Details
7.14.2 Carrier Biomed Major Business
7.14.3 Carrier Biomed Alzheimer's Disease Diagnosis Product and Services
7.14.4 Carrier Biomed Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.14.5 Carrier Biomed Recent Developments/Updates
7.14.6 Carrier Biomed Competitive Strengths & Weaknesses
8 Industry Chain Analysis
8.1 Alzheimer's Disease Diagnosis Industry Chain
8.2 Alzheimer's Disease Diagnosis Upstream Analysis
8.3 Alzheimer's Disease Diagnosis Midstream Analysis
8.4 Alzheimer's Disease Diagnosis Downstream Analysis
9 Research Findings and Conclusion
10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
About Us:
GlobaI Info Research
Web: https://www.globalinforesearch.com
CN: 0086-176 6505 2062
HK: 00852-58030175
US: 001-347 966 1888
Email: report@globalinforesearch.com
Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.